Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
A

SOHO 2021 Highlights on Myeloid/Lymphoid Neoplasms With Eosinophilia and TKI Fusion Genes: Treatment

By Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021) FEATURING Andreas Reiter
By Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021) FEATURING Andreas Reiter
10 views
September 23, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Related Content

AUTOPLAY
29:17
UChicago Medicine

Overview of Recent Updates in MPNs and MDS

Feat. S. Kosuri
16:32
UChicago Medicine

Personalizing Therapeutic Approaches in Leukemia and Myeloid Maligna…

Feat. A. Patel
11:29
SOHO 2022 Tenth Annual Meeting

SOHO 2022 Next Questions: Myeloproliferative Neoplasms

Feat. S. Verstovsek
17:16
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on Accelerated Phase MPN: What Is It and What t…

Feat. O. Odenike
17:41
SOHO Brazil 2023

[Portugese] 2023 SOHO® Brazil: "MDS/MPN Overlap Syndromes"

Feat. A. De Almeida
08:13
GRACE

2020 Update on Blood Cancer Diagnosis: Morphology, Cytogenetic/Molec…

Feat. M. Ruiz
10:00
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Next Questions in MPN

Feat. S. Verstovsek
16:25
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Simple Guideline to Systemic Mastocytosis

Feat. J. Gotlib
17:22
UChicago Annual Updates from ASH 2019

BCL2 Inhibition in Myeloid Malignancies: Venetoclax + Azacitidine in…

Feat. O. Odenike
16:18
Dana-Farber Cancer Institute

What is Clonal Hematopoiesis and Why Does It Matter?

Feat. D. Steensma
18:50
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics

Targeted Therapy for High-Risk Myeloid Malignancies: Aza+/-Ven in Ol…

Feat. O. Odenike
25:01
Indy Hematology Review

Review of Emerging Therapies and Top Trials in Hematologic Malignanc…

Feat. R. Birhiray
12:20
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on Myeloid/Lymphoid Neoplasms With Eosinophilia…

Feat. A. Kim
22:10
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

UPenn Expert Discussion on MDS, MPN & Leukemia: Transfusion-Depe…

Feat. K. Pratz, S. McCurdy, D. Babushok, A. Perl, S. Luger, S. Saroha
11:25
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on the Treatment of Myeloid/Lymphoid Neoplasms …

Feat. A. Reiter
13:00
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on Chronic Eosinophilic Leukemia: Diagnosis and…

Feat. J. Gotlib
08:59
ASH 2021 Conference Coverage on VuMedi

ASH 2021 Update on the Outcomes of Therapy-Related Myeloid Neoplasms…

Feat. M. Shah
25:56
UChicago Annual Updates from ASH 2019

Inherited Predisposition to Myeloid Hematologic Malignancies: Why Do…

Feat. S. Feurstein
08:53
Indy Hematology Review

Eosinophilic Disorders

Feat. A. Tefferi
19:05
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics

49 y/o Female With a Concern for Primary Hematopoietic Neoplasm: Sta…

Feat. M. Drazer, L. Godley, J. Churpek, M. Perpich, K. Blazer, S. Dreike